A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)
Clinical trial NCT03347123 · TERMINATED
Trial details
- NCT number
- NCT03347123
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2021-01-29
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.